http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108440583-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108440583-B |
| titleOfInvention | Boric acid derivative and its medicinal composition |
| abstract | The invention discloses a novel boric acid derivative and a pharmaceutical composition thereof, belonging to the field of pharmaceutical chemistry. The boric acid derivative is a compound shown in a formula (I). The invention also provides application of the boric acid derivative in preparing anti-tumor drugs or proteasome inhibitor drugs, in particular application of the boric acid derivative in preparing proteasome chymotrypsin-like protease inhibitor drugs and application in preventing and/or treating cancers such as multiple myeloma and colon cancer; provides a new choice for clinically screening and/or preparing proteasome inhibitor medicines and cancer medicines such as multiple myeloma, colon cancer and the like, and has wide application prospect. |
| priorityDate | 2017-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.